Structures by: Dupont J.
Total: 21
3a in manuscript
C20H13N3OS
Molecular bioSystems (2010) 6, 6 967-975
a=8.9629(10)Å b=9.0475(11)Å c=10.4647(12)Å
α=111.391(2)° β=90.220(2)° γ=91.569(2)°
3b in manuscript
C20H13N3OS
Molecular bioSystems (2010) 6, 6 967-975
a=7.49100(10)Å b=16.4275(3)Å c=21.0326(3)Å
α=107.3780(10)° β=96.1190(10)° γ=97.8040(10)°
C24H20B,C19H21N2
C24H20B,C19H21N2
The journal of physical chemistry. B (2005) 109, 10 4341-4349
a=8.484(5)Å b=19.347(5)Å c=19.586(5)Å
α=90° β=90.506(5)° γ=90°
C19H21N2,F6P
C19H21N2,F6P
The journal of physical chemistry. B (2005) 109, 10 4341-4349
a=10.2149(5)Å b=12.5025(4)Å c=15.0057(6)Å
α=90° β=90° γ=90°
C19H21N2,BF4
C19H21N2,BF4
The journal of physical chemistry. B (2005) 109, 10 4341-4349
a=10.7207(3)Å b=10.8545(2)Å c=15.4841(4)Å
α=90° β=90° γ=90°
(Ph2CHCH2Ph)((CF3SO2)2N)
C20H19F6N3O4S2
New Journal of Chemistry (2009) 33, 1 82
a=10.0301(9)Å b=18.8620(19)Å c=12.9786(12)Å
α=90° β=93.289(6)° γ=90°
ESLJP05
C14H15F6N3O4S2
New Journal of Chemistry (2009) 33, 1 82
a=9.7783(9)Å b=15.2038(16)Å c=12.8926(14)Å
α=90° β=92.951(6)° γ=90°
1-ethyl-2,3-dimethylimidazolium tetrachloroferrate
C7H13N2,Cl4Fe
RSC Adv. (2015)
a=9.6703(1)Å b=14.3513(2)Å c=9.5744(1)Å
α=90.0000° β=94.261(1)° γ=90.0000°
C6H11N2,C3H3N2,H2O
C6H11N2,C3H3N2,H2O
Physical chemistry chemical physics : PCCP (2016) 18, 27 18297-18304
a=7.3864(4)Å b=12.0203(7)Å c=12.5938(7)Å
α=90° β=103.725(6)° γ=90°
(PhCH2CH2CH2(N2C3H3)CH3)(N(SO2CF3)
C15H17F6N3O4S2
New Journal of Chemistry (2009) 33, 1 82
a=11.1807(2)Å b=14.8585(3)Å c=12.8594(3)Å
α=90° β=105.4960(10)° γ=90°
C21H15Co2CrNO9
C21H15Co2CrNO9
Journal of the Chemical Society, Dalton Transactions (2001) 10 1634
a=8.2527(1)Å b=16.0306(1)Å c=18.2571(3)Å
α=90.00° β=99.807(1)° γ=90.00°
C28H23CrMo2NO7
C28H23CrMo2NO7
Journal of the Chemical Society, Dalton Transactions (2001) 10 1634
a=8.8575(6)Å b=17.2298(10)Å c=17.6676(11)Å
α=90.00° β=90.00° γ=90.00°
C18H13BrClN3OPdS
C18H13BrClN3OPdS
Dalton transactions (Cambridge, England : 2003) (2011) 40, 40 10535-10544
a=8.6025(4)Å b=10.4897(4)Å c=10.9885(3)Å
α=77.842(2)° β=85.148(2)° γ=67.469(2)°
C30H22Br2N4O6Pd2S2,2(CH2Cl2)
C30H22Br2N4O6Pd2S2,2(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 40 10535-10544
a=10.8302(2)Å b=26.1898(5)Å c=13.3993(2)Å
α=90.00° β=90.00° γ=90.00°
1-ethyl-2,3-dimethylimidazolium chloride
C7H13N2,Cl
Crystal Growth & Design (2015) 15, 11 5207
a=7.99132(6)Å b=16.45676(13)Å c=6.68451(6)Å
α=90.0000° β=104.0416(5)° γ=90.0000°
1-ethyl-2,3-dimethylimidazolium bromide
C7H13N2,Br
Crystal Growth & Design (2015) 15, 11 5207
a=8.35615(5)Å b=17.03644(11)Å c=6.87656(5)Å
α=90.0000° β=104.2869(4)° γ=90.0000°
1-ethyl-2,3-dimethylimidazolium bromide
C7H13N2,Br
Crystal Growth & Design (2015) 15, 11 5207
a=7.84646(8)Å b=17.33453(17)Å c=6.75078(7)Å
α=90.0000° β=100.2869(6)° γ=90.0000°
1-ethyl-2,3-dimethylimidazolium chloride
C7H13N2,Cl
Crystal Growth & Design (2015) 15, 11 5207
a=8.36352(5)Å b=16.48723(11)Å c=6.71641(5)Å
α=90.0000° β=105.5362(4)° γ=90.0000°
((1,3-Bis(mes)H2Im))(L)(Cl)2Ru
C38H49Cl2F6N4OPRu
Organometallics (2009) 28, 15 4527
a=18.8740(6)Å b=8.5802(3)Å c=25.5347(8)Å
α=90° β=106.169(2)° γ=90°
1,3-dimethylimidazolium Tetrabromoferrate
C5H9N21,Br4Fe1
Inorganic chemistry (2014) 53, 16 8384-8396
a=6.745(3)Å b=14.364(3)Å c=6.759(3)Å
α=90.0000° β=90.80(2)° γ=90.0000°
1,3-dimethylimidazolium Tetrabromoferrate
C5H9N21,Br4Fe1
Inorganic chemistry (2014) 53, 16 8384-8396
a=6.7520(1)Å b=14.3717(3)Å c=6.7500(2)Å
α=90.0000° β=90.676(1)° γ=90.0000°